•  
  •  
  •  
  •  

2025-06-21 08:04:51

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Amic Forging Limited enters into agreement for asset purchase
  • BuzzWorks Expands Hyderabad Footprint
  • GMM Pfaudler Limited arm enters into contract for EUR 33.2 Mn
  • TD Power Systems Limited receives order valued at approx. Rs. 67 crore
  • Diageo India to acquire NAO Spirits, maker of premium Indian craft gin brands like 'Greater Than' and 'Hapusa'

Keywords Selected:  INE326A01037

Research

  • Lupin - Q1FY23 Result Update - Margin disappointment continues - HOLD

Stock Report

  • Lupin and Sino Universal Pharmaceuticals Sign License and Supply Agreement for Tiotropium DPI in China
  • Lupin receives tentative approval from U.S. FDA for Oxcarbazepine ER Tablets
  • Punita Lal Joins Lupin Board as Additional Director
  • Lupin receives approval from U.S. FDA for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg
  • Lupin Ltd recommends dividend of Rs. 12
  • Lupin launches Eslicarbazepine Acetate Tablets in the United States
  • Lupin receives approval from U.S. FDA for Tolvaptan Tablets
  • Lupin Diagnostics achieves NABL Accreditation for All Greenfield Labs
  • Lupin receives EIR from US FDA for its Injectable Facility in Nagpur
  • US court passes order against Lupin Ltd in Myrbetriq® patent case
  • Lupin announces the acquisition of Renascience in the United Kingdom
  • Lupin Digital Health introduces comprehensive Post-Procedure Home-Based Care Guide in Collaboration with the American College of Cardiology
  • Nanomi Receives CMO Award for Life Science Leadership in Drug Delivery
  • Lupin awarded EcoVadis Silver Medal for Sustainability Excellence, Ranks among the Top 15% Globally
  • Lupin receives tentative approval from U.S. FDA for Amifampridine Tablets
  • Lupin Launches Rivaroxaban Tablets USP, 2.5mg in the United States
  • Lupin Secures a Place in the Prestigious S&P Global Sustainability Yearbook 2025
  • Lupin Receives EIR from U. S. FDA for its Somerset Manufacturing Facility
  • Lupin acquires Huminsulin from Lilly to Enhance Diabetes Portfolio
  • Lupin Digital Health partners with Medicover Hospitals for Comprehensive Post Discharge Cardiac Care
  • Lupin acquires 3 Trademarks from Boehringer Ingelheim to Strengthen Diabetes Portfolio
  • Lupin Launches First Generic of Pred Forte in the United States
  • Lupin Launches Aptivate Achi Bhookh Fest in Mumbai and Suburbs
  • Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations

Latest Post

  • Amic Forging Limited enters into agreement for asset purchase
  • BuzzWorks Expands Hyderabad Footprint
  • GMM Pfaudler Limited arm enters into contract for EUR 33.2 Mn
  • TD Power Systems Limited receives order valued at approx. Rs. 67 crore
  • Diageo India to acquire NAO Spirits, maker of premium Indian craft gin brands like 'Greater Than' and 'Hapusa'


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024